Taro Pharmaceutical Industries Ltd (NYSE:TARO)

101.91
Delayed Data
As of 11:19am ET
 +0.79 / +0.78%
Today’s Change
93.01
Today|||52-Week Range
128.46
-2.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues196.4M161.3M169.9M155.5M
 
 
 
 
 
Cost of Goods Sold48.7M41.0M40.8M48.3M
 
 
 
 
 
Depreciation And Amortization3.8M3.8M4.0M4.2M
 
 
 
 
 
 
Operating ExpensesGross Income143.9M116.5M125.1M102.9M
 
 
 
 
 
General Expenses42.1M38.9M36.3M39.3M
 
 
 
 
 
Research And Development19.9M14.7M18.0M17.5M
 
 
 
 
 
Total Operating Expenses94.6M83.7M81.1M91.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income101.8M77.6M88.8M63.6M
 
 
 
 
 
Extraordinary Charge-92.0K0.000.00-1.9M
 
 
 
Other Expenses-5.1M-17.5M-33.9M4.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income100.3M64.6M59.5M71.1M
 
 
 
 
 
Income Taxes-17.3M-10.0M-6.9M-54.4M
 
 
 
 
 
Minority Interest-23.0K-58.0K-90.0K-1.4M
 
 
 
 
 
Discontinued Operations-38.0K-47.0K-145.0K-47.0K
 
 
 
 
 
Net Income83.0M54.5M52.4M18.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS40.6M40.5M40.3M40.1M
 
 
 
 
 
Shares To Calculate EPS Diluted40.6M40.5M40.3M40.1M
 
 
 
 
 
 
Earnings Per ShareEPS$2.05$1.35$1.30$0.45
 
 
 
 
 
EPS Diluted$2.05$1.35$1.30$0.45